Millennium Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-20,197
| Closed | -$959K | – | 5970 |
|
|
2025
Q3 | $959K | Sell |
20,197
-294,792
| -94% | -$14.3M | ﹤0.01% | 4661 |
|
|
2025
Q2 | $16.8M | Buy |
314,989
+84,125
| +36% | +$3.82M | 0.01% | 1754 |
|
|
2025
Q1 | $9.35M | Buy |
230,864
+214,128
| +1,279% | +$9.08M | 0.01% | 2263 |
|
|
2024
Q4 | $466K | Sell |
16,736
-57,892
| -78% | -$1.75M | ﹤0.01% | 4801 |
|
|
2024
Q3 | $2.14M | Sell |
74,628
-94,963
| -56% | -$2.48M | ﹤0.01% | 3643 |
|
|
2024
Q2 | $3.98M | Sell |
169,591
-622,984
| -79% | -$13.3M | ﹤0.01% | 2927 |
|
|
2024
Q1 | $20M | Buy |
792,575
+535,381
| +208% | +$12.9M | 0.01% | 1556 |
|
|
2023
Q4 | $6.01M | Buy |
+257,194
| New | +$5.07M | ﹤0.01% | 2631 |
|
|
2023
Q3 | – | Sell |
-4,884
| Closed | -$227K | – | 6070 |
|
|
2023
Q2 | $228K | Sell |
4,884
-5,282
| -52% | -$242K | ﹤0.01% | 5048 |
|
|
2023
Q1 | $389K | Sell |
10,166
-236,851
| -96% | -$10.6M | ﹤0.01% | 4745 |
|
|
2022
Q4 | $13.5M | Buy |
+247,017
| New | +$10.6M | 0.01% | 1821 |
|
|
2022
Q3 | – | Sell |
-520,769
| Closed | -$4.92M | – | 7024 |
|
|
2022
Q2 | $4.92M | Buy |
520,769
+455,525
| +698% | +$4.75M | ﹤0.01% | 2830 |
|
|
2022
Q1 | $926K | Buy |
65,244
+45,501
| +230% | +$797K | ﹤0.01% | 4610 |
|
|
2021
Q4 | $418K | Buy |
+19,743
| New | +$438K | ﹤0.01% | 5229 |
|
|
2021
Q2 | – | Sell |
-85,492
| Closed | -$2.48M | – | 6467 |
|
|
2021
Q1 | $2.48M | Sell |
85,492
-178,919
| -68% | -$5.42M | ﹤0.01% | 3328 |
|
|
2020
Q4 | $6.82M | Buy |
264,411
+108,097
| +69% | +$3.01M | ﹤0.01% | 2147 |
|
|
2020
Q3 | $4.81K | Buy |
156,314
+26,749
| +21% | +$935K | 0.01% | 1881 |
|
|
2020
Q2 | $3.23M | Buy |
129,565
+65,026
| +101% | +$1.49M | ﹤0.01% | 2152 |
|
|
2020
Q1 | $1.37M | Buy |
+64,539
| New | +$1.38M | ﹤0.01% | 2272 |
|
|
2019
Q4 | – | Sell |
-73,621
| Closed | -$1.67M | – | 4160 |
|
|
2019
Q3 | $1.67M | Sell |
73,621
-94,125
| -56% | -$2.19M | ﹤0.01% | 2555 |
|
|
2019
Q2 | $3.21M | Buy |
+167,746
| New | +$3.18M | ﹤0.01% | 2106 |
|
Other funds holding AKRO
Millennium Management's AKRO Position: Q4 2025 in Review
Millennium Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 20,197 shares — an estimated $959K sold.
Millennium Management first reported a position in AKRO in Q2 2019 and held it in 21 quarters. The position peaked at $20M in Q1 2024. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Millennium Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Millennium Management sold 20,197 Akero Therapeutics shares in Q4 2025, an estimated $959K.
- Millennium Management first reported a position in Akero Therapeutics in Q2 2019 and held it in 21 quarters.
- Millennium Management's Akero Therapeutics position peaked at $20M in Q1 2024.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.